Curet Myriam 4

4 · INTUITIVE SURGICAL INC · Filed Mar 11, 2026

AI-generated summary of this filing

Updated Mar 11, 2026

Intuitive Surgical EVP Myriam Curet Exercises Options and Sells 105 Shares

What Happened

Myriam Curet, EVP and Chief Medical Officer of Intuitive Surgical (ISRG), exercised stock options and sold the resulting 105 shares on March 10, 2026. She exercised 105 option shares at a strike of $229.39 (cost $24,086) and sold those 105 shares in the open market at $493.95 for total proceeds of $51,865. Net proceeds before taxes/fees ≈ $27,779.
This is a sale following an option exercise (often a routine liquidity event), not a new purchase.

Key Details

Transaction date: 2026-03-10.
- Option exercise (code M): 105 shares acquired at $229.39 — $24,086.
- Open-market sale (code S): 105 shares sold at $493.95 — $51,865.
- Derivative surrender (code M): 105 shares reported disposed at $0.00 (reporting detail related to the option instrument).
Shares owned after transaction: not disclosed in the filing excerpt.
Footnotes:
- F1: Transaction executed under a Rule 10b5-1 trading plan that expires July 29, 2026.
- F2: The option has a vesting schedule (12.5% at six months from Feb 10, 2023, then 1/48th monthly thereafter).
Filing timeliness: Report filed on 2026-03-11 for a 2026-03-10 transaction (appears timely).

Context

This was an exercise-plus-sale (effectively a cashless exercise): the insider converted options into shares and immediately sold them in the open market. Such transactions often reflect routine option exercises or planned sales under 10b5-1 plans rather than a directional bet on the stock.

Form 4

Period: 2026-03-10

EVP & Chief Medical Officer

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-03-10$229.39/sh+105$24,086→ 105 total
Sale
Common Stock
[F1]
2026-03-10$493.95/sh−105$51,865→ 0 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
[F1][F2]
2026-03-10−105→ 1,152 total
Exercise: $229.39Exp: 2030-02-27→ Common Stock (105 underlying)

Holdings

Footnotes (2)

[F1]The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026.
[F2]12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

Signature

By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet|2026-03-11

1 file